Cargando…

An Italian programme for COVID-19 infection in multiple sclerosis

Detalles Bibliográficos
Autor principal:	Sormani, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191287/ https://www.ncbi.nlm.nih.gov/pubmed/32359409 http://dx.doi.org/10.1016/S1474-4422(20)30147-2

Ejemplares similares

The Italian multiple sclerosis register
por: Trojano, Maria, et al.
Publicado: (2018)

COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
por: Albanese, Angela, et al.
Publicado: (2022)

Italian multicentre observational study of the prevalence of CCSVI in multiple sclerosis (CoSMo study): rationale, design, and methodology
por: Comi, Giancarlo, et al.
Publicado: (2013)

Assessing heterogeneity of treatment effect in multiple sclerosis trials
por: Sormani, Maria Pia, et al.
Publicado: (2023)

Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
por: Schiavetti, Irene, et al.
Publicado: (2022)

The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis
por: Branger, Pierre, et al.
Publicado: (2016)

COVID-19 vaccine hesitancy among Italian people with multiple sclerosis
por: Proietti, Francesca, et al.
Publicado: (2022)

Quantitative Assessment of Finger Motor Impairment in Multiple Sclerosis
por: Bonzano, Laura, et al.
Publicado: (2013)

Modeling the Distribution of New MRI Cortical Lesions in Multiple Sclerosis Longitudinal Studies
por: Sormani, Maria Pia, et al.
Publicado: (2011)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context
por: Sormani, Maria Pia, et al.
Publicado: (2021)

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2016)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Cerebellar volume as imaging outcome in progressive multiple sclerosis
por: Inglese, Matilde, et al.
Publicado: (2017)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
por: Schiavetti, Irene, et al.
Publicado: (2023)

Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis
por: Ostini, Camilla, et al.
Publicado: (2021)

Improving the Characterization of Radiologically Isolated Syndrome Suggestive of Multiple Sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2011)

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register
por: Mosconi, Paola, et al.
Publicado: (2023)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis
por: Uher, Tomas, et al.
Publicado: (2017)

Enhancing diversity of clinical trial populations in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2020)

MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation?
por: Egger, Christine, et al.
Publicado: (2016)

Insights for Fostering Resilience in Young Adults With Multiple Sclerosis in the Aftermath of the COVID-19 Emergency: An Italian Survey
por: Donisi, Valeria, et al.
Publicado: (2021)

Klotho and vitamin D in multiple sclerosis: an Italian study
por: Scazzone, Concetta, et al.
Publicado: (2019)

Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis
por: Pia Sormani, Maria, et al.
Publicado: (2020)

Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis
por: Jonkman, Laura E., et al.
Publicado: (2015)

Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets
por: Cortese, Rosa, et al.
Publicado: (2022)

Nitrosative Stress Molecules in Multiple Sclerosis: A Meta-Analysis
por: Förster, Moritz, et al.
Publicado: (2021)

Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis
por: Landi, Doriana, et al.
Publicado: (2020)

Enhancing involvement of people with multiple sclerosis in clinical trial design
por: Gray, Emma, et al.
Publicado: (2023)

Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015–2017 Prevalence
por: Moccia, Marcello, et al.
Publicado: (2020)

Predictors of hospital-based multidisciplinary rehabilitation effects in persons with multiple sclerosis: a large-scale, single-centre study
por: Groppo, Elisabetta, et al.
Publicado: (2019)

Estimating individual treatment effect on disability progression in multiple sclerosis using deep learning
por: Falet, Jean-Pierre R., et al.
Publicado: (2022)

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study
por: Pastò, Luisa, et al.
Publicado: (2012)

Italian Validation of the 12-Item Multiple Sclerosis Walking Scale
por: Solaro, C., et al.
Publicado: (2015)

Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis
por: Pengo, Marta, et al.
Publicado: (2022)

Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey
por: Portaccio, Emilio, et al.
Publicado: (2021)

Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey
por: Landi, Doriana, et al.
Publicado: (2021)

Improving the efficiency of clinical trials in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jdkem2qcmlbu470hugg7v5uso8